17:29 , Sep 14, 2018 |  BC Week In Review  |  Financial News

Neurological organoid company System1 raises $25M in series A

System1 Biosciences Inc. (San Francisco, Calif.) raised $25 million in a series A round co-led by CRV and Pfizer Ventures. Alexandria Venture Investments, Dolby Family Ventures, Longevity Fund, Riot Ventures, Kinled Holding, Wilmot Ventures, Webb...
19:51 , Apr 27, 2018 |  BC Week In Review  |  Company News

Mammoth emerges to bring CRISPR into diagnostic space

Mammoth Biosciences (San Francisco, Calif.) debuted on April 26 with a CRISPR-based diagnostic platform and an exclusive license to IP covering work from CRISPR pioneer Jennifer Doudna. While CRISPR-based therapeutics have garnered the most attention...
16:11 , Apr 26, 2018 |  BC Extra  |  Company News

Mammoth emerges, among first diagnostic-focused CRISPR companies

Mammoth Biosciences (San Francisco, Calif.) debuted on Thursday with a CRISPR-based diagnostic platform and an exclusive license to IP covering work from CRISPR pioneer Jennifer Doudna. While CRISPR-based therapeutics have garnered the most attention from...
16:09 , Apr 26, 2018 |  BC Innovations  |  Emerging Company Profile

Mammoth makes Dx CRISPR

Mammoth Biosciences emerged from stealth with an exclusive license to Jennifer Doudna’s CRISPR-based diagnostics technology, which could enable faster diagnosis of a range of diseases than PCR-based sequencing and culture-based techniques and be more adaptable...